☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
AbCellera Enters into a License Agreement with Everest to Discover Antibody Therapies
September 23, 2021
Innovent Reports NMPA's Acceptance of sNDA for Sintilimab as 1L Treatment for Esophageal Squamous Cell Carcinoma
September 23, 2021
Abbott's Epic Plus Tissue Valves Receives the US FDA's Approval for the Treatment of Mitral or Aortic Valve Replacement
September 23, 2021
Incyte's Jakafi (ruxolitinib) Receives the US FDA's Approval for the Treatment of Chronic Graft-Versus-Host Disease
September 23, 2021
Gilead Reports Results of Veklury (remdesivir) in P-III Trial for the Treatment of COVID-19
September 23, 2021
Immunic Sign a License Agreement with University Medical Center Goettingen for IMU-838 & N4-Hydroxycytidine to Treat Viral Inf...
September 23, 2021
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions